Why Federal Medicaid Disproportionate Share Hospital Payments Should Not Be Cut

In the Commonwealth Fund’s To the Point blog, Sara Rosenbaum, the Harold and Jane Hirsh Professor of Health Law and Policy at the Milken Institute School of Public Health, makes a case for staving off harmful cuts to state Medicaid disproportionate share hospital (DSH) payments. 

Why FDA Should Implement Some of the National Academies’ Recommendations for Making Medicines Affordable

As the National Academies of Sciences, Engineering, and Medicine points out in a recent report, Making Medicines Affordable: A National Imperative, the U.S. biopharmaceutical sector has been successful in developing and delivering effective drugs for improving health and fighting disease over the past decades.  Many medical conditions that were long deemed untreatable can now be cured or managed effectively.

Trump Administration Contraceptive Rule Creates Problems for Both Women’s Health and Scientific Integrity

The Jacobs Institute of Women's Health joined colleagues at the National Partnership for Women & Families and the Union of Concerned Scientists in submitting comments on a Trump Administration rule allowing employers that offer health insurance to stop covering contraception without cost-sharing.

The Senate’s Tax Reform Bill Puts Public Health at Risk

In a sneak attack akin to Pearl Harbor, the Senate sought to deal a death blow to health insurance coverage under the Affordable Care Act by its last minute addition of the repeal of the individual responsibility mandate into its tax reform bill.  The Congressional Budget Office estimated that this would lead health insurance coverage to fall by 13 million and to raise health insurance premiums by 10 percent.  Combined with Pr